4//SEC Filing
Rhodes Jennifer J 4
Accession 0001415889-24-003039
CIK 0001070494other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:09 PM ET
Size
7.9 KB
Accession
0001415889-24-003039
Insider Transaction Report
Form 4
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
Transactions
- Award
Stock Option (Right to Buy)
2024-02-06+126,589→ 126,589 totalExercise: $25.74Exp: 2034-02-05→ Common Stock (126,589 underlying) - Award
Restricted Stock Units
2024-02-06+25,889→ 25,889 total→ Common Stock (25,889 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 6, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]50% of the restricted stock units vest on February 6, 2026 and 25% vest on each of February 6, 2027 and February 6, 2028.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001568249
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:09 PM ET
- Size
- 7.9 KB